Pulmotect develops novel therapeutic products for the treatment of lung infections.
$5.9M
Sep 16, 2024
-
Procyrion is a Texas-based medical device company that designs and manufactures percutaneous mechanical circulatory support devices to treat heart failure patients.
$57.7M
Dec 12, 2023
-
Brevitest is a Switzerland-based clinical DaaS platform that analyzes and assists enzyme immunoassays for early-stage detection of diseases.
$2.2M
Dec 10, 2020
-
Procyrion is a Texas-based medical device company that designs and manufactures percutaneous mechanical circulatory support devices to treat heart failure patients.
$30M
Jun 24, 2019
-
Procyrion is a Texas-based medical device company that designs and manufactures percutaneous mechanical circulatory support devices to treat heart failure patients.
$10M
Oct 08, 2015
-
Frequently Asked Questions about Fannin
What is Fannin investing in?
Fannin has invested in 5 companies including Pulmotect, Procyrion and Brevitest
What company did Fannin invest in?
Fannin invested in a total 5 companies including Pulmotect, Procyrion and Brevitest
What are the top 5 investments by Fannin?
The top companies in which Fannin invested are Pulmotect, Procyrion, Brevitest, Procyrion and Procyrion
